Mariantonietta Cicoira

Summary

Affiliation: ANMCO Research Center
Country: Italy

Publications

  1. ncbi Use of digitalis in the treatment of heart failure: data from the Italian Network on Congestive Heart Failure (IN-CHF)
    Alberto Camerini
    Department of Cardiac Rehabilitation, La Colletta Hospital, Arenzano GE, Italy
    Ital Heart J 5:523-9. 2004
  2. ncbi Improving practice patterns in heart failure through a national cardiological network: the case of ACE-inhibitors
    Maurizio Porcu
    Heart Failure and Cardiac Transplant Unit, G Brotzu Hospital, Cagliari, Italy
    Ital Heart J 3:730-7. 2002
  3. ncbi In-hospital and one-year outcomes of patients with high-risk acute myocardial infarction treated with thrombolysis or primary coronary angioplasty
    Giuseppe Steffenino
    Department of Cardiology, S Croce e Carle Hospital, Cuneo, Italy
    Ital Heart J 5:136-45. 2004
  4. ncbi Body mass index, prognosis and mode of death in chronic heart failure: results from the Valsartan Heart Failure Trial
    Mariantonietta Cicoira
    Department of Biomedical and Surgical Sciences, Section of Cardiology, University of Verona, Piazzale Stefani, 1 Verona, Italy, and Hospital General Universitari Vall D Hebron, Department of Cardiology, Barcelona, Spain
    Eur J Heart Fail 9:397-402. 2007
  5. ncbi Baseline characteristics of patients recruited in the AREA IN-CHF study (Antiremodelling Effect of Aldosterone Receptors Blockade with Canrenone in Mild Chronic Heart Failure)
    Alessandro Boccanelli
    Department of Cardiology, San Giovanni Addolorata Hospital, Rome, Italy
    J Cardiovasc Med (Hagerstown) 8:683-91. 2007
  6. ncbi [The elderly patient with heart failure at hospital cardiology units]
    Donatella Del Sindaco
    U O di Cardiologia, IRCCS, INRCA, Roma
    Ital Heart J Suppl 3:145-53. 2002
  7. ncbi Rationale and design of the GISSI-Atrial Fibrillation Trial: a randomized, prospective, multicentre study on the use of valsartan, an angiotensin II AT1-receptor blocker, in the prevention of atrial fibrillation recurrence
    Marcello Disertori
    Department of Cardiology, S Chiara Hospital, Trento, Italy
    J Cardiovasc Med (Hagerstown) 7:29-38. 2006
  8. ncbi Precipitating factors and decision-making processes of short-term worsening heart failure despite "optimal" treatment (from the IN-CHF Registry)
    C Opasich
    S Maugeri Foundation, Institute of Care and Scientific Research, Cardiology Division, Pavia, Italy
    Am J Cardiol 88:382-7. 2001
  9. ncbi Comparison of electrocardiographic criteria for diagnosis of left ventricular hypertrophy in hypertension: the MAVI study
    P Verdecchia
    Department of Cardiology, Hospital R Silvestrini, Perugia, Italy
    Ital Heart J 1:207-15. 2000
  10. ncbi Comparison of one-year outcome in women versus men with chronic congestive heart failure
    C Opasich
    Department of Cardiology, Fondazione Salvatore Maugeri, Pavia, Italy
    Am J Cardiol 86:353-7. 2000

Detail Information

Publications63

  1. ncbi Use of digitalis in the treatment of heart failure: data from the Italian Network on Congestive Heart Failure (IN-CHF)
    Alberto Camerini
    Department of Cardiac Rehabilitation, La Colletta Hospital, Arenzano GE, Italy
    Ital Heart J 5:523-9. 2004
    ....
  2. ncbi Improving practice patterns in heart failure through a national cardiological network: the case of ACE-inhibitors
    Maurizio Porcu
    Heart Failure and Cardiac Transplant Unit, G Brotzu Hospital, Cagliari, Italy
    Ital Heart J 3:730-7. 2002
    ..We evaluated whether participation in a specialist network and the use of a common database would impact on the compliance with CHF guidelines...
  3. ncbi In-hospital and one-year outcomes of patients with high-risk acute myocardial infarction treated with thrombolysis or primary coronary angioplasty
    Giuseppe Steffenino
    Department of Cardiology, S Croce e Carle Hospital, Cuneo, Italy
    Ital Heart J 5:136-45. 2004
    ..The aim of this study was to observe the outcomes of high-risk patients with acute myocardial infarction treated with primary angioplasty and intravenous thrombolysis in a community setting...
  4. ncbi Body mass index, prognosis and mode of death in chronic heart failure: results from the Valsartan Heart Failure Trial
    Mariantonietta Cicoira
    Department of Biomedical and Surgical Sciences, Section of Cardiology, University of Verona, Piazzale Stefani, 1 Verona, Italy, and Hospital General Universitari Vall D Hebron, Department of Cardiology, Barcelona, Spain
    Eur J Heart Fail 9:397-402. 2007
    ..To assess the relationship between body mass index (BMI), mortality and mode of death in chronic heart failure (CHF) patients; to define the shape of the relationship between BMI and mortality...
  5. ncbi Baseline characteristics of patients recruited in the AREA IN-CHF study (Antiremodelling Effect of Aldosterone Receptors Blockade with Canrenone in Mild Chronic Heart Failure)
    Alessandro Boccanelli
    Department of Cardiology, San Giovanni Addolorata Hospital, Rome, Italy
    J Cardiovasc Med (Hagerstown) 8:683-91. 2007
    ..AREA IN-CHF was planned to investigate the effects of canrenone on progression of LV remodelling in mild HF...
  6. ncbi [The elderly patient with heart failure at hospital cardiology units]
    Donatella Del Sindaco
    U O di Cardiologia, IRCCS, INRCA, Roma
    Ital Heart J Suppl 3:145-53. 2002
    ..Targeted clinical trials and rigorous observational studies to favor the implementation of specific guidelines into clinical practice in the elderly are needed...
  7. ncbi Rationale and design of the GISSI-Atrial Fibrillation Trial: a randomized, prospective, multicentre study on the use of valsartan, an angiotensin II AT1-receptor blocker, in the prevention of atrial fibrillation recurrence
    Marcello Disertori
    Department of Cardiology, S Chiara Hospital, Trento, Italy
    J Cardiovasc Med (Hagerstown) 7:29-38. 2006
    ..The GISSI-Atrial Fibrillation (AF) trial is a randomized, prospective, parallel group, placebo-controlled, multicentre study designed to test whether angiotensin II AT1-receptor blockers can reduce atrial fibrillation recurrence...
  8. ncbi Precipitating factors and decision-making processes of short-term worsening heart failure despite "optimal" treatment (from the IN-CHF Registry)
    C Opasich
    S Maugeri Foundation, Institute of Care and Scientific Research, Cardiology Division, Pavia, Italy
    Am J Cardiol 88:382-7. 2001
    ..Nearly 1/3 of precipitating factors can be prevented. Patient education and avoidance of inappropriate treatment may reduce the number of relapses...
  9. ncbi Comparison of electrocardiographic criteria for diagnosis of left ventricular hypertrophy in hypertension: the MAVI study
    P Verdecchia
    Department of Cardiology, Hospital R Silvestrini, Perugia, Italy
    Ital Heart J 1:207-15. 2000
    ..In a large population of subjects with hypertension we tested some standard ECG criteria in their sensitivity and specificity for LV hypertrophy. LV mass at echocardiography was the reference standard...
  10. ncbi Comparison of one-year outcome in women versus men with chronic congestive heart failure
    C Opasich
    Department of Cardiology, Fondazione Salvatore Maugeri, Pavia, Italy
    Am J Cardiol 86:353-7. 2000
    ....
  11. ncbi Nationwide survey on acute heart failure in cardiology ward services in Italy
    Luigi Tavazzi
    Department of Cardiology, IRCCS Policlinico S Matteo, Piazzale Golgi, 2 27100 Pavia, Italy
    Eur Heart J 27:1207-15. 2006
    ..Chronic heart failure (HF) is recognized as an important public health problem but little attention has been focused on acute-stage HF...
  12. ncbi [BRING-UP 2: presentation of the study]
    G Fabbri
    Centro Studi ANMCO, Firenze
    Ital Heart J Suppl 1:1043-6. 2000
    ..In this last category the recommendations for beta-blockers should be expanded, but in routine conditions of care the administration of these drugs still needs careful guide and observation...
  13. doi Trial-generated profiles for implantation of electrical devices in outpatients with heart failure: real-world prevalence and 1-year outcome
    Giuseppe Boriani
    Institute of Cardiology, University of Bologna, Bologna, Italy
    J Eval Clin Pract 16:82-91. 2010
    ....
  14. ncbi Exercise intolerance in chronic heart failure: mechanisms and therapies. Part I
    Massimo F Piepoli
    Heart Failure Unit, Department of Cardiology, G da Saliceto Hospital, Piacenza, Emilia Romagna, Italy
    Eur J Cardiovasc Prev Rehabil 17:637-42. 2010
    ..We believe that a better knowledge of the pathophysiology of this syndrome may contribute to the management of the patients and to the improvement in their stress tolerance and quality of life...
  15. ncbi Identification of high-risk chronic heart failure patients in clinical practice: role of changes in left ventricular function
    Mariantonietta Cicoira
    Department of Medicine, Section of Cardiology, University of Verona, Verona, Italy
    Clin Cardiol 35:580-4. 2012
    ..Left ventricular (LV) dysfunction and remodeling are key pathophysiological features underlying disease progression in chronic heart failure (CHF)...
  16. doi Prognostic value of indeterminable anaerobic threshold in heart failure
    Piergiuseppe Agostoni
    Centro Cardiologico Monzino, IRCCS, Milano, Italy
    Circ Heart Fail 6:977-87. 2013
    ..In patients with heart failure (HF), during maximal cardiopulmonary exercise test, anaerobic threshold (AT) is not always identified. We evaluated whether this finding has a prognostic meaning...
  17. ncbi Aortic valve sclerosis: a marker of significant obstructive coronary artery disease in patients with chest pain?
    Luca Conte
    Section of Cardiology, Department of Biochemical and Surgical Sciences, University of Verona, Verona, Italy
    J Am Soc Echocardiogr 20:703-8. 2007
    ..However, whether AVS can be used as a marker of obstructive CAD (obCAD) in patients with chest pain is unknown. We hypothesized that AVS is a predictive marker for obCAD in patients hospitalized for chest pain...
  18. doi Increased aortic pulse wave velocity as measured by echocardiography is strongly associated with poor prognosis in patients with heart failure
    Stefano Bonapace
    Section of Cardiology, Department of Medicine, University and Azienda Ospedaliera Universitaria Integrata of Verona, Verona, Italy
    J Am Soc Echocardiogr 26:714-20. 2013
    ..However, it remains unknown if an increased aortic PWV predicts poor prognosis in patients with HF, independent of peak exercise oxygen consumption...
  19. pmc Left atrial volume provides independent and incremental information compared with exercise tolerance parameters in patients with heart failure and left ventricular systolic dysfunction
    Andrea Rossi
    Department of Biomedical and Surgical Sciences, Section of Cardiology, University of Verona, Italy
    Heart 93:1420-5. 2007
    ..It is unknown whether LAV provides independent and incremental information compared with exercise tolerance parameters...
  20. pmc Aortic and mitral annular calcifications are predictive of all-cause and cardiovascular mortality in patients with type 2 diabetes
    Andrea Rossi
    Section of Cardiology, Department of Medicine, University and Azienda Ospedaliera Universitaria Integrata of Verona, Verona, Italy
    Diabetes Care 35:1781-6. 2012
    ..To examine the association of aortic valve sclerosis (AVS) and mitral annulus calcification (MAC) with all-cause and cardiovascular mortality in type 2 diabetic individuals...
  21. ncbi Carotid atherosclerotic plaque instability in patients with acute myocardial infarction
    Andrea Rossi
    Dipartimento di Scienze Biomediche e Chirurgiche, Sezione di Cardiologia, University of Verona, Verona, Italy
    Int J Cardiol 111:263-6. 2006
    ..We aimed to analyze whether patients with acute myocardial infarction (AMI) might have a higher proportion of unstable plaques in the carotid arteries compared with patients who had had no acute coronary events...
  22. doi Exercise intolerance in chronic heart failure: mechanisms and therapies. Part II
    Massimo F Piepoli
    Heart Failure Unit, Department of Cardiology, G da Saliceto Hospital, Piacenza, Emilia Romagna, Italy
    Eur J Cardiovasc Prev Rehabil 17:643-8. 2010
    ..We believe that a better knowledge of the pathophysiology of this syndrome may contribute to the management of the patients and to the improvement in their stress tolerance and quality of life...
  23. pmc Treatment of chronic heart failure with beta adrenergic blockade beyond controlled clinical trials: the BRING-UP experience
    A P Maggioni
    ANMCO Research Centre, Florence, Italy
    Heart 89:299-305. 2003
    ..Despite these impressive results, implementing the use of beta blockade in clinical practice appears slow and difficult. The BRING-UP study was designed to tackle this problem...
  24. doi EURObservational Research Programme: the Heart Failure Pilot Survey (ESC-HF Pilot)
    Aldo P Maggioni
    ANMCO Research Center, Florence, Italy
    Eur J Heart Fail 12:1076-84. 2010
    ..This pilot study was specifically aimed at validating the structure, performance, and quality of the data set, for continuing the survey into a permanent registry...
  25. ncbi Functional mitral regurgitation in patients with aortic stenosis: prevalence, clinical correlates and pathophysiological determinants: a quantitative prospective study
    Andrea Rossi
    Department of Medicine, Section of Cardiology, University of Verona, P le Stefani 1, 37126 Verona, Italy
    Eur Heart J Cardiovasc Imaging 15:631-6. 2014
    ..However, the association of these variables with mitral effective regurgitant orifice (ERO) is still unknown...
  26. doi General anaesthesia for external electrical cardioversion of atrial fibrillation: experience of an exclusively cardiological procedural management
    Giovanni Morani
    Department of Biomedical and Surgical Sciences, Division of Cardiology, University of Verona, Verona, Italy
    Europace 12:1558-63. 2010
    ..The aim of this study was to evaluate the feasibility and safety of inducing anaesthesia for EC of atrial fibrillation (AF) exclusively by the cardiologic team with anaesthetists on-hand...
  27. pmc Progression of Left Ventricular Dysfunction and Remodelling under Optimal Medical Therapy in CHF Patients: Role of Individual Genetic Background
    Marzia Rigolli
    Division of Cardiology, Department of Biomedical and Surgical Sciences, University of Verona, 37129 Verona, Italy
    Cardiol Res Pract 2011:798658. 2011
    ..05 for all). Conclusions. ACE I/D and β1AR Arg389Gly polymorphisms are independent predictors of reverse remodeling and systolic function recovery in CHF patients under optimal treatment...
  28. ncbi Association of aortic valve sclerosis and coronary artery disease in patients with severe nonischemic mitral regurgitation
    Andrea Rossi
    Department of Biomedical and Surgical Science, Cardiology Section, University of Verona, Verona, Italy
    Clin Cardiol 26:579-82. 2003
    ..The presence of aortic valve sclerosis accounts for a higher rate of ischemic events and increased cardiovascular mortality. It may reflect coronary artery disease (CAD) because of a shared pathologic background...
  29. doi Oxidative stress and hyperuricaemia: pathophysiology, clinical relevance, and therapeutic implications in chronic heart failure
    Corinna Bergamini
    Department of Biomedical and Surgical Sciences, Division of Cardiology, Ospedale Civile Maggiore, University of Verona, Piazzale Stefani 1, Verona, Italy
    Eur J Heart Fail 11:444-52. 2009
    ....
  30. doi Myocardial infarction in a young patient with a previous history of repeated thrombophlebitis: combination of factor V Leiden and prothrombin G20210A gene polymorphisms with coronary artery disease
    Antonio Mugnolo
    Division of Cardiology, Department of Biomedical and Surgical Sciences, University of Verona, Verona, Italy
    J Cardiovasc Med (Hagerstown) 11:125-6. 2010
    ....
  31. pmc Syncope in cardiac amyloidosis and chronic ischemic heart disease: A case report
    Giacomo Mugnai
    Department of Medicine, Division of Cardiology, University of Verona, Verona, Italy
    Exp Clin Cardiol 16:51-3. 2011
    ....
  32. ncbi Beta-blockade therapy in chronic heart failure: diastolic function and mitral regurgitation improvement by carvedilol
    S Capomolla
    Salvatore Maugeri Foundation, Institute of Medical Care and Research, Pavia, Italy
    Am Heart J 139:596-608. 2000
    ....
  33. ncbi The 'real' woman with heart failure. Impact of sex on current in-hospital management of heart failure by cardiologists and internists
    C Opasich
    Department of Cardiology, Salvatore Maugeri Foundation, Pavia, Italy
    Eur J Heart Fail 6:769-79. 2004
    ..To identify differences between sexes in the clinical profile, use of resources, management and outcome in a large population of 'real world' patients with heart failure (HF)...
  34. ncbi Does in-patient ECG monitoring have an impact on medical care in chronic heart failure patients?
    C Opasich
    S Maugeri Foundation, Institute of Care and Scientific Research, Department of Cardiology, Pavia, Italy
    Eur J Heart Fail 2:281-5. 2000
    ..Heart failure patients' management in non-intensive care units might be improved by telemetry monitoring. However, telemetry adds the cost and evidence of this effectiveness is not available...
  35. ncbi Chromogranin A in heart failure; a novel neurohumoral factor and a predictor for mortality
    C Ceconi
    Cardiovascular Pathophysiology Research Centre, Salvatore Maugeri Foundation, IRCCS, Gussago, Italy
    Eur Heart J 23:967-74. 2002
    ....
  36. ncbi Relationship between cognitive impairment and clinical status in chronic heart failure patients
    S Callegari
    Psychology Unit, Fondazione S Maugeri, Clinica del Lavoro e della Riabilitazione, IRCCS, Scientific Institute of Montescano, PV, Italy
    Monaldi Arch Chest Dis 58:19-25. 2002
    ..The aim of the present study is to analyse the relationship between cognitive impairment and cardiovascular variables in a sample of patients with chronic heart failure for assessment or candidated for heart transplant...
  37. ncbi Reproducibility of the six-minute walking test in chronic heart failure patients
    G D Pinna
    Department of Biomedical Engineering, S Maugeri Foundation, Institute of Care and Scientific Research, Medical Center of Montescano PV, Italy
    Stat Med 19:3087-94. 2000
    ..When follow-up studies > or = 3 months are performed, unpredictable changes in individual walking performance due to spontaneous clinical evolution are to be expected. Their clinical significance, however, is not known...
  38. ncbi Chronic infusion of dobutamine and nitroprusside in patients with end-stage heart failure awaiting heart transplantation: safety and clinical outcome
    S Capomolla
    Fondazione S Maugeri, Clinica del Lavoro e della Riabilitazione, IRCCS Istituto Scientifico di Montescano, Pavia, Italy
    Eur J Heart Fail 3:601-10. 2001
    ..No data comparing the use and efficacy of chronic intravenous inotropic and vasodilator therapy in patients with advanced heart failure are available...
  39. ncbi Body mass and survival in patients with chronic heart failure without cachexia: the importance of obesity
    Constantinos H Davos
    Department of Cardiac Medicine, National Heart and Lung Institute, London, United Kingdom
    J Card Fail 9:29-35. 2003
    ..Cachexia in chronic heart failure carries a poor prognosis, but little is known about the influence of body mass on the prognosis of noncachectic heart failure patients...
  40. ncbi Myocardial viability independently influences left ventricular diastolic function in the early phase after acute myocardial infarction
    Andrea Rossi
    Dipartimento di Scienze Biomediche e Chirurgiche, Sezione di Cardiologia, Universita di Verona, Italy
    J Am Soc Echocardiogr 15:1490-5. 2002
    ..However, intrinsic characteristics of the infarcted tissue (necrosis or viability) may also play a role. We aimed to evaluate whether myocardial viability (Mviab) has an influence on LVEDP...
  41. ncbi Clinical characteristics and survival of patients with chronic heart failure and prolonged QRS duration
    Paul R Kalra
    Clinical Cardiology, National Heart and Lung Institute, Dovehouse Street, London SW3 6LY, UK
    Int J Cardiol 86:225-31. 2002
    ..Whilst resynchronisation of ventricular conduction may benefit patients with QRS>150 ms, this has yet to be determined for patients with moderate QRS prolongation...
  42. ncbi Determinants and prognostic value of left atrial volume in patients with dilated cardiomyopathy
    Andrea Rossi
    Dipartimento di Scienze Biomediche e Chirurgiche, Sezione di Cardiologia, Universita di Verona, Verona, Italy
    J Am Coll Cardiol 40:1425. 2002
    ..We aimed to investigate the determinants of left atrial (LA) volume and its prognostic value in patients with dilated cardiomyopathy (DCM)...
  43. ncbi Impact of body mass index on short-term outcome after acute myocardial infarction: does excess body weight have a paradoxical protective role?
    Ilaria Nicoletti
    Dipartimento di Scienze Biomediche e Chirurgiche, Sezione di Cardiologia, Universita degli Studi di Verona, Italy
    Int J Cardiol 107:395-9. 2006
    ..However, the relation between BMI (body mass index) and outcome in patients with AMI has not been completely clarified. The aim of our study was to assess the impact of BMI on short-term outcome after AMI...
  44. ncbi Elevated serum uric acid levels are associated with diastolic dysfunction in patients with dilated cardiomyopathy
    Mariantonietta Cicoira
    Divisione Clinicizzata di Cardiologia, Universita degli Studi di Verona, Italy
    Am Heart J 143:1107-11. 2002
    ..To assess whether serum uric acid, which is a marker of impaired oxidative metabolism, might correlate with left ventricular systolic and diastolic dysfunction in patients with chronic heart failure (CHF)...
  45. ncbi Insulin resistance in moderate chronic heart failure is related to hyperleptinaemia, but not to norepinephrine or TNF-alpha
    Wolfram Doehner
    Department of Clinical Cardiology, National Heart and Lung Institute, Imperial College School of Medicine, Dovehouse St, London SW3 6LY, UK
    Int J Cardiol 83:73-81. 2002
    ..The purpose of this study was to examine in patients with CHF and in comparison to healthy controls subjects whether norepinephrine, TNFalpha or leptin relate to insulin sensitivity...
  46. ncbi Relation of aldosterone "escape" despite angiotensin-converting enzyme inhibitor administration to impaired exercise capacity in chronic congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy
    Mariantonietta Cicoira
    Divisione Clinicizzata di Cardiologia, Universita degli Studi di Verona, Verona, Italy
    Am J Cardiol 89:403-7. 2002
    ..Thus, aldosterone escape is associated with reduced exercise capacity in patients with CHF. This factor does not seem to be linked with hemodynamic mechanisms or with a reduced skeletal muscle bulk...
  47. ncbi Chronic heart failure with preserved left ventricular ejection fraction: diagnostic and prognostic value of left atrial size
    Andrea Rossi
    Dipartimento di Scienze Biomediche e Chirurgiche, Sezione di Cardiologia Universita degli Studi di Verona, Verona, Italy, and Department of Clinical Cardiology, Royal Brompton Hospital, National Heart and Lung Institute, London, UK
    Int J Cardiol 110:386-92. 2006
    ..Data on prognostic markers in such patients are limited. We analyzed the prevalence and prognostic value of left atrial (LA) size in this condition...
  48. ncbi The role of angiotensin-converting enzyme polymorphism in congestive heart failure
    Mara Pilati
    Dipartimento di Scienze Biomediche e Chirurgiche, Sezione di Cardiologia, Universita di Verona, Ospedale Civile Maggiore, Piazzale Stefani 1, 37126 Verona, Italy
    Congest Heart Fail 10:87-93; quiz 94-5. 2004
    ....
  49. ncbi Aortic stiffness correlates with an increased extracellular matrix turnover in patients with dilated cardiomyopathy
    Stefano Bonapace
    Divisione Clinicizzata di Cardiologia, Dipartimento di Scienza Biomediche e Chirurgiche, Universita di Verona, Verona, Italy
    Am Heart J 152:93.e1-6. 2006
    ..Therefore, we investigated whether the serum aminoterminal propeptide of type III collagen (PIIINP), an established marker of ECM turnover and tissue fibrosis in DCM, was associated with aortic stiffness in DCM patients...
  50. ncbi Effects of ACE gene insertion/deletion polymorphism on response to spironolactone in patients with chronic heart failure
    Mariantonietta Cicoira
    Dipartimento di Scienze Biomediche e Chirurgiche, Sezione di Cardiologia, Universita degli Studi di Verona, Verona, Italy
    Am J Med 116:657-61. 2004
    ..We hypothesized that the benefits of spironolactone, which inhibits downstream elements of ACE-mediated abnormalities, may depend on ACE genotype...
  51. ncbi Independent and additional prognostic value of aminoterminal propeptide of type III procollagen circulating levels in patients with chronic heart failure
    Mariantonietta Cicoira
    Dipartimento di Scienze Biomediche e Chirurgiche, Sezione di Cardiologia, Universita degli Studi di Verona, Italy
    J Card Fail 10:403-11. 2004
    ..We aimed to determine whether aminoterminal-propeptide of type III procollagen (PIIINP), a marker of extracellular matrix turnover, might provide prognostic information in CHF patients...
  52. ncbi Ischemic etiology of heart failure identifies patients with more severely impaired exercise capacity
    Stefania De Feo
    Divisione Clinicizzata di Cardiologia, Ospedale Civile Maggiore Piazzale Stefani 1, I 37126 Verona, Italy
    Int J Cardiol 104:292-7. 2005
    ..Our purpose was to evaluate the influence of CHF etiology on peak VO2 and VE/VCO2 slope, independently of demographic, clinical, Doppler-echocardiographic and neurohormonal factors...
  53. ncbi Statin use and survival in patients with chronic heart failure--results from two observational studies with 5200 patients
    Stefan D Anker
    Applied Cachexia Research, Department of Cardiology, Charite Campus Virchow Klinikum, Berlin, Germany
    Int J Cardiol 112:234-42. 2006
    ..Treatment with statins may lead to a lower mortality in CHF, independent of cholesterol levels, CHF etiology and clinical status...
  54. ncbi Enhanced prognostic value from cardiopulmonary exercise testing in chronic heart failure by non-linear analysis: oxygen uptake efficiency slope
    Lewis Ceri Davies
    National Heart and Lung Institute, Imperial College of Science, Technology and Medicine, London, UK
    Eur Heart J 27:684-90. 2006
    ..We evaluated the physiology of OUES and assessed its potential for prognostic information in patients with CHF...
  55. ncbi Growth hormone resistance in chronic heart failure and its therapeutic implications
    Mariantonietta Cicoira
    Divisione Clinicizzata di Cardiologia, Universita di Verona, Verona, Italy
    J Card Fail 9:219-26. 2003
    ..The pathophysiologic importance of GH and insulin-like growth factor (IGF)-I in these conditions will be discussed...
  56. ncbi Association of deranged adrenal steroid metabolism with anemia in chronic heart failure
    Darlington O Okonko
    Clinical Cardiology, National Heart and Lung Institute, Imperial College, London, UK
    Am J Cardiol 96:101-3. 2005
    ..The cortisol/DHEA ratio was independently and inversely associated with hemoglobin concentrations, suggesting that alterations of the steroid milieu may play a role in the pathogenesis of anemia in CHF...
  57. ncbi Long-term, dose-dependent effects of spironolactone on left ventricular function and exercise tolerance in patients with chronic heart failure
    Mariantonietta Cicoira
    Dipartimento di Scienze Biomediche e Chirurgiche, Sezione di Cardiologia Universita degli Studi di Verona, P Le Stefani, I 37126 Verona, Italy
    J Am Coll Cardiol 40:304-10. 2002
    ..This study was designed to assess the effects of spironolactone (SP) on left ventricular (LV) function and exercise tolerance in patients with chronic heart failure (CHF)...
  58. ncbi Inhibitors of angiotensin-converting enzyme and physical function in older women
    Mariantonietta Cicoira
    Lancet 360:1099; author reply 1099-100. 2002
  59. ncbi Uric acid and survival in chronic heart failure: validation and application in metabolic, functional, and hemodynamic staging
    Stefan D Anker
    Applied Cachexia Research Unit, Charite, Campus Virchow Klinikum, Berlin, Germany
    Circulation 107:1991-7. 2003
    ..Serum uric acid (UA) could be a valid prognostic marker and useful for metabolic, hemodynamic, and functional (MFH) staging in chronic heart failure (CHF)...
  60. ncbi [Muscle changes and exercise intolerance in congestive heart failure: main role of the periphery]
    Mariantonietta Cicoira
    Sezione di Cardiologia, Dipartimento di Scienze Biomediche e Chirurgiche, Ospedale Civile Maggiore, Piazzale Stefani, 1 37126 Verona
    Ital Heart J Suppl 3:908-12. 2002
    ..Exercise training, in fact, allows to obtain an improvement in pVO2, which parallels important biochemical and histological changes in the skeletal muscles...
  61. ncbi Biventricular pacing
    Mariantonietta Cicoira
    N Engl J Med 355:1738; author reply 1739. 2006
  62. ncbi Prediction of mortality in chronic heart failure from peak oxygen consumption adjusted for either body weight or lean tissue
    Mariantonietta Cicoira
    Divisione Clinicizzata di Cardiologia, Universita degli Studi di Verona, Italy
    J Card Fail 10:421-6. 2004
    ..We hypothesized that correcting pVO2 for lean tissue rather than total body weight would improve the prediction of prognosis in patients with chronic heart failure (CHF)...
  63. ncbi Prognostic utility of growth differentiation factor-15 in patients with chronic heart failure
    Tibor Kempf
    Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany
    J Am Coll Cardiol 50:1054-60. 2007
    ..We explored the prognostic utility of growth differentiation factor (GDF)-15 in patients with chronic heart failure (CHF)...